Keryx Biopharmaceuticals, Inc. (KERX) Drug Fails FDA Trial But CEO States It’s Not The End Of Keryx
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) had disappointing news on March 7, 2008. They announced that their Sulonex SUN-MICRO Phase 3…
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) had disappointing news on March 7, 2008. They announced that their Sulonex SUN-MICRO Phase 3…
The Most Recent Quarter ended November 2007 has been nearly pyrotechnic for this company. Net income has jumped 67%, while…
No company, big or small, can escape the business cycle altogether. All stocks are affected by macroeconomic factors beyond management…
In order to drive its commitment to minimize reliance on fossil oil, the company has assembled a dedicated team of…
Clek Media Inc., (Clek) a digital media consulting firm dedicated to enhancing the value and financial returns of its clients…
Airspan, a leading worldwide provider of wireless voice and broadband data systems and solutions for the fixed and mobile WiMAX…
MRV, a leading provider of network equipment and services as well as optical components, has named Guy Avidan, previously serving…
MedeFile International, Inc. (OTCBB:MDFI), a company specializing in electronic medical records management solutions, was recently announced as a “Stock to…
Fund.com, Inc. (OTCBB: FNDM) today announced the appointment of Gregory H. Webster as president of the financial services information publisher,…
Shares of Zila Inc. (ZILA) soared nearly 9% Tuesday to close at 62 cents after the oral diagnostics company announced…